{
    "clinical_study": {
        "@rank": "109451", 
        "acronym": "Sono RCT", 
        "arm_group": [
            {
                "arm_group_label": "Navigation only group", 
                "arm_group_type": "Other", 
                "description": "Sonowand system will be used for navigation control arm as well as sononavigation experimental arm.Navigation will be used to plan the craniotomy and throughout the procedure as desired by the operating surgeon. At no point of time however will the Ultrasound be used."
            }, 
            {
                "arm_group_label": "SonoRCT Test group", 
                "arm_group_type": "Experimental", 
                "description": "Surgery to resect the tumor with the aid of sononavigation. In addition to the navigation function, the Ultrasound will be available at all times. This study will help in assessing the usefulness sononavigation in improving radicality of resection in malignant gliomas and also to access the accuracy of SonoWand in predicting residue."
            }
        ], 
        "brief_summary": {
            "textblock": "Phase 3 randomized open labeled trials will evaluate the 3 D navigable ultrasound (SonoWand)\n      in improving the extent of resection in intra-axial brain tumors. All patients will undergo\n      resective surgery. In the experimental arm, a navigable 3 D ultrasound will be used. In the\n      standard arm, only navigation will be used. This study will help in assessing the usefulness\n      sononavigation in improving radicality of resection in malignant gliomas and also to access\n      the accuracy of SonoWand in predicting residue (histopathological correlation)."
        }, 
        "brief_title": "3D Ultra Sound for Resection of Brain Tumors", 
        "completion_date": {
            "#text": "March 2017", 
            "@type": "Anticipated"
        }, 
        "condition": "Patients With Resectable Brain Tumors", 
        "condition_browse": {
            "mesh_term": "Brain Neoplasms"
        }, 
        "detailed_description": {
            "textblock": "Routine presurgical evaluation of all patients will be conducted. The preoperative use of\n      steroids, antiepileptics and other medications would be as per standard procedure and would\n      be documented. In addition detailed MRI evaluation will be performed (including contrast\n      enhanced MRI study, diffusion MRI, perfusion MR, MR spectroscopy, dynamic-contrast-enhanced\n      MRI for permeability studies, as well as functional MRI, and tractography if required) not\n      more than 1 week prior to the date of surgery.\n\n      Navigation specific MR sequences would be performed in all patients (both arms)."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          1. All radiologically-suspected, previously untreated, supratentorial malignant gliomas\n             being considered for debulking surgery.\n\n          2. Adults (above 18 years)\n\n          3. Eligible for surgical therapy (craniotomy not stereotactic biopsy )\n\n          4. Resectability : A lesion would be considered \"resectable\" if the surgeons feel that\n             all the radiologically imaged lesion can be removed (with reasonable certainty). Only\n             deemed resectable lesions will be included\n\n        Exclusion Criteria:\n\n          1. Unfit for GA\n\n          2. Unwilling for the study\n\n          3. Unresectable lesion"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "72", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "May 17, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02150564", 
            "org_study_id": "TMC-ACTREC 101"
        }, 
        "intervention": [
            {
                "arm_group_label": "SonoRCT Test group", 
                "description": "Initially a 2D acquisition will be performed and ultrasound parameters adjusted to obtain the best image resolution. Then anatomical landmarks will be identified if possible and the lesioncharacterized. Once the lesion is identified a rapid 3D-US acquisition will be performed. Tumor resection will proceed guided by the 3D US images using a trackable pointer to navigate. Repeat 3D US images will be obtained as many times as required during the surgery to update the information as tumor debulking proceeds. A final US will be obtained at the end of the procedure and after dural closure", 
                "intervention_name": "Sonowand", 
                "intervention_type": "Device"
            }, 
            {
                "arm_group_label": "Navigation only group", 
                "description": "Routine microneurosurgical procedures would be adopted in all cases.Sonowand system will be used for navigation control arm as well as sononavigation experimental arm. Image registration (on the previously imported DICOM images) will be done on the system and after positioning, patient-toimage registration will be completed. The Registration accuracy will be documented.", 
                "intervention_name": "Navigation", 
                "intervention_type": "Procedure"
            }
        ], 
        "is_fda_regulated": "No", 
        "keyword": [
            "Malignant gliomas", 
            "Sono RCT"
        ], 
        "lastchanged_date": "June 3, 2014", 
        "location": {
            "contact": {
                "email": "aliasgar.moiyadi@gmail.com", 
                "last_name": "Aliasgar V Moiyadi, M Ch (Neurosurgery)", 
                "phone": "91-22-27405076", 
                "phone_ext": "5076"
            }, 
            "facility": {
                "address": {
                    "city": "Mumbai", 
                    "country": "India", 
                    "state": "Maharashtra", 
                    "zip": "410210"
                }, 
                "name": "Advanced Centre for Treatment Research and Education in Cancer"
            }, 
            "investigator": {
                "last_name": "Aliasgar V Moiyadi, M Ch, DNB (Neurosurgery)", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "India"
        }, 
        "number_of_arms": "2", 
        "official_title": "Role of 3-D Navigable Ultrasound in Resection of Intra-axial Brain Tumors - A Randomized Controlled Study", 
        "other_outcome": [
            {
                "description": "-", 
                "measure": "Further resection prompted", 
                "safety_issue": "No", 
                "time_frame": "Intraoperative"
            }, 
            {
                "description": "-", 
                "measure": "Whether use of Sonowand prompted a further resection after the surgeon thought it was complete (unanticipated residue)", 
                "safety_issue": "No", 
                "time_frame": "Intra operative"
            }, 
            {
                "description": "-", 
                "measure": "Survival (overall and progression-free)", 
                "safety_issue": "No", 
                "time_frame": "3 years"
            }
        ], 
        "overall_contact": {
            "email": "aliasgar.moiyadi@gmail.com", 
            "last_name": "Dr Aliasgar V Moiyadi, M Ch Neurosurgery", 
            "phone": "022-27405076", 
            "phone_ext": "5076"
        }, 
        "overall_official": {
            "affiliation": "Prof and Neurosurgeon", 
            "last_name": "Aliasgar V Moiyadi, M Ch Neurosurgery", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "India: Drugs Controller General of India", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 3", 
        "primary_completion_date": {
            "#text": "January 2017", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Measure: Volumetric MRI -  residual tumor (in cc)", 
            "measure": "Percentage of patients where Gross total resection (GTR) achieved", 
            "safety_issue": "No", 
            "time_frame": "Post operative within 72 hrs."
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02150564"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Tata Memorial Hospital", 
            "investigator_full_name": "Dr Aliasgar V Moiyadi", 
            "investigator_title": "Prof and Neurosurgeon", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "description": "Measure: Sensitivity, Specificity, PPV, NPV", 
            "measure": "Accuracy of US", 
            "safety_issue": "No", 
            "time_frame": "Post operative within 72 hrours"
        }, 
        "source": "Tata Memorial Hospital", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Tata Memorial Hospital", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "March 2014", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Diagnostic", 
        "study_type": "Interventional", 
        "verification_date": "June 2014"
    }
}